Sponsored by:
Sprint Nextel (S)
Yahoo! (YHOO)
Cisco (CSCO)
Netflix (NFLX)
Focus Stocks
Featured Stories
Time Warner Inc. Reports Strong Results
Moody’s Reports Earnings
Emerson Near Resistance
Advance Auto Parts Upside Looming?
Above Resistance - Starbucks
TradersHuddle Scanner - High Volume For Medtronic
Published on Tuesday, 24 August 2010 11:38 Written by Christian Paolinetti
New York, August 24th (TradersHuddle.com) - Unusual high volume detected on shares of Medtronic, Inc. (NYSE:MDT), early in the trading session. Medtronic is currently trading lower by 9.6%, so definitely the sellers in control, as the stock's volume is already above average.
Medtronic, Inc. (NYSE:MDT) develops therapeutic and diagnostic medical products. Its principal products include those for bradycardia pacing, tachyarrhythmia management, atrial fibrillation management, heart failure management, heart valve replacement, malignant and non-malignant pain, and movement disorders.
Medtronic has already traded 1.957 times its 3-month average volume, and has calculated support and resistance at $34.35 and $38.08 respectively. Traders like to use volume as their lie detector for price action moves through predefined trading ranges.
The overall market index S&P 500 is trading lower by -1.03% from its previous trading close, which means that Medtronic stock is underperforming the overall market.
Related Articles
- Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
- Approaching Resistance - Medtronic
- Medtronic Announces First Patient Enrollment in Clinical Trial Assessing Guideline-Based Heart Failure Management in Primary Care Setting
- Data Presented at STS Reinforce Positive Clinical Outcomes for Medtronic CoreValve® System Using Direct Aortic Approach
- Medtronic Announces FDA Approval of DF4 High-Voltage Connector System for Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Devices
- Medtronic Launches New Minimally Invasive Cardiac Surgery Products Through Exclusive Distribution Agreement with Miami Instruments
- Medtronic Completes Enrollment of Extreme Risk Patient Group in CoreValve® U.S. Pivotal Trial
- First Patient Enrolled in Medtronic-Supported Head-to-Head Clinical Trial Comparing Cryoballoon Ablation to RF Ablation for Paroxysmal Atrial Fibrillation
- Medtronic Announces 510(k) Clearance for the Aquamantys SBS 5.0 Sheathed Bipolar Sealer for Spine Surgery
- Medtronic Endurant® II AAA Stent Graft System Launches Internationally with CE Mark
Related Partner Headlines
- Medtronic Announces First Patient Enrollment in Clinical Trial Assessing Guideline-Based Heart Failure Management in Primary Care Setting - Benzinga
- Medtronic Says Data from Corevalue Demonstrates Positive Outcomes - Benzinga
- Medtronic Stock To Go Ex-dividend Tomorrow (MDT) - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Care Loser - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Care Winner - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Services Loser - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Services Loser - TheStreet.com
- Medtronic Inc. Stock Upgraded (MDT) - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Services Loser - TheStreet.com
- Medtronic Inc. (MDT): Today's Featured Health Services Winner - TheStreet.com
Volatile market? That's when profit potential skyrockets for options traders. Now you can get up to 50 trade opportunities a week from top options experts -- plus much more -- on our exciting new site OptionsProfits.
Try it FREE!
TradersHuddle Search
| Sponsored By:
|
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
Stock Market
Loading
